Back to Screener

Healthcare

Allergy Therapeutics plc(AGYTF)

Live Price

Offline

$0.13

+0.00% today

1Y Change

+52.94%

Window

Jun 26, 2025 โ†’ Jun 24, 2026

Market Cap
$510.00M
Revenue Growth
+36.9%
EPS Growth
+21.5%
Dividend Yield
0.0%

Coverage: 256 bars ยท Jun 26, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Allergy Therapeutics plc (AGYTF) is a Healthcare stock with a market cap of $510.00M and listed on OTC. The stock last traded around $0.13 and up 52.9% across the available one-year price window (Jun 26, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of +36.9%, EPS growth of +21.5%, a dividend yield of 0.0%. What stands out right now is revenue +36.9%, EPS +21.5%, free cash flow -23.5% with operating margin -60.2% and ROIC -84.3%. Valuation already assumes a fairly strong business story at price/sales 9.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines AGYTF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

AGYTF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

AGYTF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

AGYTF Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for AGYTF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Next earningsSep 30, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Sep 30, 26
TBD
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Sep 30
โ€”
Mar 31, 26
โ€”
-0.01
Est -0.01
0.0%
48876.4B
Est 48903.4B
-0.1%
Mar 31
โ€”
Dec 11, 25
-0.01
Est โ€”
โ€”
28848.0B
Est 32906.0B
-12.3%
Dec 11
โ€”
Mar 31, 25
-0.00
Est โ€”
โ€”
42576.0B
Est 42574.9B
0.0%
Mar 31
โ€”
Nov 6, 24
โœ“
-0.01
Est -0.01
+0.8%
27373.3B
Est 27343.0B
+0.1%
Nov 6
โ€”
Mar 27, 24
-0.01
Est โ€”
โ€”
42435.1B
Est 42772.8B
-0.8%
Mar 27
โ€”
Jun 30, 23
โœ—
-0.03
Est -0.01
-153.8%
24928.9B
Est 31732.5B
-21.4%
Jun 30
โ€”
Dec 31, 22
โœ—
-0.01
Est -0.01
-30.5%
49041.1B
Est 48255.1B
+1.6%
Dec 31
โ€”
Jun 30, 22
โœ—
-0.02
Est -0.01
-72.0%
29220.2B
Est 29332.1B
-0.4%
Jun 30
โ€”
Dec 31, 21
0.01
Est โ€”
โ€”
65687.1B
Est 65832.7B
-0.2%
Dec 31
โ€”
Jun 30, 21
-0.01
Est โ€”
โ€”
41865.5B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 20
0.01
Est โ€”
โ€”
73496.8B
Est 73815.3B
-0.4%
Dec 31
โ€”
Jun 30, 20
-0.01
Est โ€”
โ€”
34564.0B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 19
0.01
Est โ€”
โ€”
64693.5B
Est 67474.0B
-4.1%
Dec 31
โ€”
Jun 30, 19
-0.01
Est โ€”
โ€”
34225.5B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 18
0.01
Est โ€”
โ€”
62745.6B
Est โ€”
โ€”
Dec 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener